JESSICA ZEHR: Open Payments
NPI 1356613871 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 47 payments from 12 companies in 2025. Trend: 2023 $1,029 · 2024 $1,148 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $158 |
| ABBVIE INC. | 13 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Celgene Corporation | 1 | $17 |
Products named: NURTEC ODT, QULIPTA, TRINTELLIX, UBRELVY, TRELEGY ELLIPTA, AIRSUPRA, INSPIRE, CAPLYTA.
Industry payments across IN — which companies pay providers there.
